Benzinga | Oct 12, 2021 07:09AM EDT

SVB Leerink Maintains Outperform on Affimed, Lowers Price Target to $12

SVB Leerink analyst Daina Graybosch maintains Affimed (NASDAQ:AFMD) with a Outperform and lowers the price target from $13 to $12.